These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17671679)

  • 1. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
    Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
    Luo CF; Zhu RQ; Wang H; Lu YL
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
    Liu R; Pu DM; Cheng YX; Yin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Yoshida H; Sumi T; Hyun Y; Nakagawa E; Hattori K; Yasui T; Morimura M; Honda K; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(1):45-9. PubMed ID: 12469143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
    Dong P; Li X; Yu Z; Lu G
    J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival.
    Goncharuk IV; Vorobjova LI; Lukyanova NY; Chekhun VF
    Exp Oncol; 2009 Sep; 31(3):179-81. PubMed ID: 19783962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
    Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
    Xu FL; Li YL; Wang ZD; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):396-400. PubMed ID: 12974081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
    Wu SH; Zhang J; Li Y; Li JM
    Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of vascular endothelial growth factor and nm23-H1 gene and their relation to the prognosis of breast cancer in young women].
    Huang ZH; Su GQ; Mao QG; Wang QZ; Li Z; Yu JL; Fan YF
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1398-401. PubMed ID: 15604068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
    Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
    Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle.
    Formenti S; Felix J; Salonga D; Danenberg K; Pike MC; Danenberg P
    Clin Cancer Res; 2000 Dec; 6(12):4653-7. PubMed ID: 11156216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.